Generation of two iPSC lines from healthy donor with a heterozygous mutation in the VPS13B gene

The human induced pluripotent stem cell (iPSC) lines, iCS-MAF1-1 and iCS-MAF1-11, were generated from fibroblasts. The donor has a heterozygous mutation in the VPS13B gene, which manifests in her child as Cohen syndrome. It is a Golgi pathology, characterized by postnatal microcephaly and delayed gr...

Full description

Saved in:
Bibliographic Details
Published in:Stem cell research 2022-03, Vol.59, p.102648-102648, Article 102648
Main Authors: Chechetkina, S.A., Khabarova, A.A., Chvileva, A.S., Kurchenko, O.M., Smirnov, A.V., Yunusova, A.M., Kotov, I.N., Musatova, E.V., Pomerantseva, E.A., Volovikov, E.A., Lagarkova, M.A., Shnaider, T.A., Pristyazhnyuk, I.E.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The human induced pluripotent stem cell (iPSC) lines, iCS-MAF1-1 and iCS-MAF1-11, were generated from fibroblasts. The donor has a heterozygous mutation in the VPS13B gene, which manifests in her child as Cohen syndrome. It is a Golgi pathology, characterized by postnatal microcephaly and delayed growth and mental development. However, the process underlying pathological changes leading to the onset of the disease is still unknown. The use of iPSC will allow describing the early stages of neurogenesis, which is undoubtedly relevant for identifying key stages of development, at which phenotypic manifestations of mutations in the VPS13B gene are found.
ISSN:1873-5061
1876-7753
DOI:10.1016/j.scr.2021.102648